Newsgather

court case

Stabil27 Meldungen13 QuellenZuletzt aktualisiert: gestern

Neueste Meldungen

Aged Care Residents Launch Class Action Lawsuit Against Arcare
In Entwicklung
Law·5.7.2026KI-Zusammenfassung

Aged Care Residents Launch Class Action Lawsuit Against Arcare

Residents at Arcare, a major Australian aged care provider, have filed a class action lawsuit alleging illegal charging of fees for services like high teas and exercise classes to immobile or incapacitated clients. The suit claims Arcare embedded these fees in 'signature packages' between 2020 and 2026, even for services already legally obliged or unusable by residents.

G
Guardian Australia
3 Min. Lesezeit
Fed Governor Lisa Cook Incurred Over $1.3M in Legal, Security Fees Amid Trump Administration Attacks
In Entwicklung
Politik·18.6.2026KI-Zusammenfassung

Fed Governor Lisa Cook Incurred Over $1.3M in Legal, Security Fees Amid Trump Administration Attacks

Federal Reserve Governor Lisa Cook faced over $1.3 million in legal and security costs due to attacks from the Trump administration, including accusations of mortgage fraud by Bill Pulte. Cook denied the claims, asserting political motivation. A Supreme Court case stemming from her firing by Trump could impact the Fed's independence.

G
Guardian Business
2 Min. Lesezeit
Pianist Sues Melbourne Symphony Orchestra for Discrimination Over Gaza Comments
In Entwicklung
Law·18.5.2026KI-Zusammenfassung

Pianist Sues Melbourne Symphony Orchestra for Discrimination Over Gaza Comments

Pianist Jayson Gillham is suing the Melbourne Symphony Orchestra, alleging unlawful discrimination due to his views on the Gaza conflict. Gillham claims a cancelled concert was an attempt to silence him after he dedicated a performance to journalists killed by Israeli forces. The judge emphasized the trial will focus on the contract dispute, not the broader Middle East conflict.

G
Guardian World
2 Min. Lesezeit
Elon Musk Testifies in $134bn Lawsuit Against OpenAI Over For-Profit Conversion
In Entwicklung
Business·1.5.2026KI-Zusammenfassung

Elon Musk Testifies in $134bn Lawsuit Against OpenAI Over For-Profit Conversion

Elon Musk continued his testimony in a $134bn lawsuit against OpenAI, alleging co-founder Sam Altman and president Greg Brockman broke a foundational agreement by converting the AI company from a non-profit to a for-profit structure. Musk, who co-founded OpenAI in 2015 and donated approximately $38m from 2016-2020, is seeking to undo the for-profit conversion and redirect damages to OpenAI's non-profit arm. OpenAI's attorneys have argued Musk was always aware of for-profit plans and is "motivated by jealousy" after leaving the company in 2018. The three-week trial in Oakland, California has featured contentious exchanges and previously private communications revealing the formation of the AI company.

G
Guardian Business
3 Min. Lesezeit
When Algorithms Get It Wrong: My Court Case Against Gothenburg's School Allocation System
In Entwicklung
Technik·30.4.2026KI-Zusammenfassung

When Algorithms Get It Wrong: My Court Case Against Gothenburg's School Allocation System

In 2020, Gothenburg deployed an algorithm to allocate school places but the system used 'crow flies' distances instead of actual walking routes, displacing around 700 children to schools miles from their homes across rivers. The author, a researcher and affected parent, sued the city but her case was dismissed because she couldn't access the algorithm's code to prove it was unlawful. She compares the case to the UK Post Office and Dutch childcare benefits scandals, arguing that procedural frameworks remain analogue while opaque algorithmic systems make life-altering decisions without accountability.

G
Guardian Business
6 Min. Lesezeit
Musk v. Altman: OpenAI For-Profit Conversion Trial Underway in California
In Entwicklung
Law·30.4.2026KI-Zusammenfassung

Musk v. Altman: OpenAI For-Profit Conversion Trial Underway in California

Elon Musk's high-stakes lawsuit against Sam Altman and OpenAI began this week in Oakland, California federal court. Musk, who co-founded OpenAI in 2015, alleges the company breached its founding agreement by converting from a non-profit focused on benefiting humanity to a for-profit structure. He is seeking $134bn in damages and reversal of the conversion. OpenAI denies the claims, arguing Musk was aware of for-profit plans and is "motivated by jealousy" after leaving in 2018. The three-week trial features dramatic testimony, with Musk's former lieutenant Jared Birchall confirming approximately $38M in donations from 2016-2020. The outcome could impact OpenAI's planned $1tn IPO and benefit Musk's competing xAI venture.

G
Guardian Business
4 Min. Lesezeit
Musk v. Altman: OpenAI Trial Reveals Private Emails as Billion-Dollar Dispute Unfolds
In Entwicklung
Law·30.4.2026KI-Zusammenfassung

Musk v. Altman: OpenAI Trial Reveals Private Emails as Billion-Dollar Dispute Unfolds

Elon Musk's lawsuit against Sam Altman and OpenAI continues in Oakland federal court, with Musk alleging the co-founders breached their 2015 founding agreement by transforming the AI company from a non-profit into a for-profit entity. Musk seeks $134bn in damages redirected to OpenAI's non-profit arm and removal of Altman and Brockman from the company. OpenAI denies the allegations, claiming Musk was always aware of for-profit plans and is "motivated by jealousy" after his 2018 departure following a failed takeover attempt. The three-week trial features blockbuster testimony from tech industry leaders and could impact OpenAI's planned $1tn IPO.

G
Guardian Business
2 Min. Lesezeit
Supreme Court Case Could Determine Future of Generic Drug 'Skinny Labeling' and Drug Costs
In Entwicklung
Gesundheit·29.4.2026KI-Zusammenfassung

Supreme Court Case Could Determine Future of Generic Drug 'Skinny Labeling' and Drug Costs

The Supreme Court is hearing Hikma v. Amarin, a case that could reshape generic drug pricing by determining whether generic manufacturers can be held liable for patent infringement when marketing medications for unpatented uses. The dispute centers on 'skinny labeling,' a strategy that has saved Medicare nearly $15 billion between 2015-2021 by bringing cheaper generics to market years before brand-name patents expire. A ruling in favor of Amarin could increase legal risks for generic companies, potentially leading to higher drug prices and longer waits for affordable medications.

N
NPR News
3 Min. Lesezeit